Wang, Yuehui <br/><br/>
Therapeutic effect of MG-132 on diabetic cardiomyopathy is associated with its suppression of proteasomal activities: roles of Nrf2 and NF-κB.  [electronic resource] 

 -  American journal of physiology. Heart and circulatory physiology  Feb 2013 
 - H567-78 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1522-1539 
<br/><br/><label>Standard No.: </label>10.1152/ajpheart.00650.2012  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antioxidants--metabolism<br/>Cysteine Proteinase Inhibitors--therapeutic use<br/>Diabetes Mellitus, Experimental--complications<br/>Diabetes Mellitus, Type 1--complications<br/>Diabetic Cardiomyopathies--diagnostic imaging<br/>Disease Models, Animal<br/>Female<br/>Gene Expression Regulation--drug effects<br/>Hypertrophy, Left Ventricular--drug therapy<br/>Leupeptins--therapeutic use<br/>Mice<br/>Mice, Transgenic<br/>Myocarditis--drug therapy<br/>NF-E2-Related Factor 2--physiology<br/>NF-kappa B--physiology<br/>Oxidative Stress--drug effects<br/>Proteasome Inhibitors--therapeutic use<br/>Ultrasonography